RNA Q1 2025 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-55.6% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$132M-8360.9% margin

Net Income

-$116M-7360.0% margin

EPS (Diluted)

$-0.90

QoQ Revenue Growth

-47.1%

Cash Flow

Operating Cash Flow

-$125M

Free Cash Flow

-$129M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$130M

Stockholders' Equity

$1.3B

Cash & Equivalents

$254M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-55.6%
Gross Profit	$2M	$3M	-45.8%
Operating Income	-$132M	-$77M	-70.4%
Net Income	-$116M	-$69M	-68.1%

Revenue Segments

Reportable Segment

$2M100%